Lindsey T. Brinton

机构：Cypress College · ORCID：0000-0002-4149-9384

发表论文 56 篇 · 总被引 919 次 · h-index 15

代表论文

A phase 1/2, first-in-human trial of ZB131, a novel antibody targeting cancer-specific plectin (CSP) in advanced solid tumors. (2023 · Journal of Clinical Oncology · 被引 2)
Comparison of Gene Expression Alterations Induced by Glucocorticoids, Thiazolidinediones, and Mifepristone Associated with Proteinuria Reduction in Puromycin Aminonucleoside-Induced Nephrotic Syndrome (PAN-NS) (2025 · Journal of the American Society of Nephrology)
Abstract 6299: ZB131 antibody-drug conjugates induce potent antitumor activity (2023 · Cancer Research)
Supplementary Figures & Tables from BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor (2023)
Data from BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor (2023)
Data from BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor (2023)